(Q45416488)

English

Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge

scientific article published on 19 May 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Christopher S Baliga

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marc van Maanen

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Michael Chastain

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Richard E Sutton

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

19 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

432-441

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The global impact of HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

New hope for an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Protective immunity induced by live attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Live attenuated AIDS viruses as vaccines: promise or peril?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Lentiviral vectors for gene delivery into cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Replication-defective HIV as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Worldwide epidemiology of human adenovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Murine T cells potently restrict human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Early transcription from nonintegrated DNA in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

The insulation of genes from external enhancers and silencing chromatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

A novel approach for producing lentiviruses that are limited to a single cycle of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Characterization and detection of artificial replication-competent lentivirus of altered host range

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2006.02.021

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45416488&oldid=2076873075"